Search Results 4131-4140 of 36783 for oral

1. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

   ... Oral biopsy, Microvascular surgery, Facial reconstruction, Skull base surgery, Glossectomy, Tracheostomy, Skin cancer reconstruction, Submandibular gland ...

2. A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant - Mayo Clinic

   antimicrobial use (oral or parenteral) is allowed. - Participants who require treatment with moderate or strong CYP3A inducers within 14 days prior to ...

3. Portal Hypertension Clinical Trials - Mayo Clinic Research

   This is an Open Label, Multicenter, pilot clinical trial to assess the efficacy and safety of an oral selective Endothelin Receptor Antagonist (ambrisentan) in ...

4. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

5. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

6. A Study of T-VEC and Radiation to Treat Localized Soft Tissue Sarcoma - Mayo Clinic

   Receiving systemic immunosuppressive therapy (> 2 weeks) including oral steroid doses > 10 mg/day of prednisone or equivalent within 2 months prior to ...

7. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

8. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

   ... Oral biopsy, Microvascular surgery, Facial reconstruction, Skull base surgery, Glossectomy, Tracheostomy, Skin cancer reconstruction, Submandibular gland ...

9. A Study To Evaluate Avacopan In Participants With ANCA-associated Vasculitis - Mayo Clinic

   Oral or vaginal candidiasis and cutaneous or nail fungal infections do not constitute an exclusion. Any of the following within 12 weeks prior to Day 1 ...

10. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

    TP-0903 is a novel oral inhibitor that targets AXL kinase and reverses the mesenchymal phenotype associated with advanced cancers. TP-0903 has demonstrated ...